Longevity

A practical framework for deciding which habits and drugs make sense for longevity, using risk benefit analysis, biomarkers, and caution around metformin.

Biological age tests can motivate change, but results vary and often reflect the past. Learn how to interpret them and prioritize proven markers.

Medical AI is speeding discovery and improving clinical work. Risk tests are becoming more accessible. Use them to motivate habits, not chase biohacks.

Turn exercise into a measurable prescription: minutes, intensity, strength progress, and VO2. Use benchmarks to adjust the plan when you are not improving.

Leucine can support strength and muscle function with age. Practical dosing with meals, what to track, and when it is unlikely to add value.

Animal studies suggest young blood factors and post exercise signals can reduce brain inflammation and improve memory. What it means and what it does not.

Strength is not just aesthetics. A simple resistance plan plus enough protein improves function, preserves muscle, and reduces frailty risk as you age.

Learn how to interpret biological age claims and demand evidence when peptides, trendy therapies, and misleading photos are used to sell rejuvenation.

Why large scale molecule discovery can unlock longevity therapeutics and radiation resilience, and how to evaluate claims with auditable evidence.

Blood pressure, apoB, VO2 max, relative strength, and body composition: five practical metrics to guide habits and health decisions for the long run.

Sleep, hydration, training, and nutrition without confusion. Lessons to feel strong now and still have energy at 80.

Therapeutic plasma exchange is being explored for aging biomarkers. Learn what it is, what is known, and which questions to ask before believing claims.

Metformin, rapamycin, and resveratrol sound promising, but data decides. A practical guide to reading trials, spotting bias, and knowing what not to do.

A practical review of GLP-1 use in obesity and cardiometabolic health, including benefits, limits, and risk management.

A critical review of plant protein, dietary fats, and policy decisions that shape diet quality and cardiometabolic outcomes.